1 |
CYP11A1
| 5件: Steroid hormone biosynthesis Steroid hormone biosynthesis, Metabolic pathways, Ovarian steroidogenesis, Cortisol synthesis and secretion, Cushing syndrome | D10950
D10950
|
Levoketoconazole
| 1件: 75 75 |
2 |
CYP11B1
| 4件: Steroid hormone biosynthesis Steroid hormone biosynthesis, Metabolic pathways, Cortisol synthesis and secretion, Cushing syndrome | D00410
D00410
|
Metyrapone
| 1件: 75 75 |
3 |
CYP11B1
| 4件: Steroid hormone biosynthesis Steroid hormone biosynthesis, Metabolic pathways, Cortisol synthesis and secretion, Cushing syndrome | D10950
D10950
|
Levoketoconazole
| 1件: 75 75 |
4 |
CYP17A1
| 6件: Steroid hormone biosynthesis Steroid hormone biosynthesis, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Cortisol synthesis and secretion, Cushing syndrome | D00351
D00351
|
Ketoconazole
| 3件: 8 8, 13, 75 |
5 |
CYP17A1
| 6件: Steroid hormone biosynthesis Steroid hormone biosynthesis, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Cortisol synthesis and secretion, Cushing syndrome | D10950
D10950
|
Levoketoconazole
| 1件: 75 75 |
6 |
AGTR1
| 9件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion, Cortisol synthesis and secretion, Cushing syndrome, Pathways in cancer, Diabetic cardiomyopathy | D00150
D00150
|
Angiotensin II
| 7件: 17 17, 19, 46, 66, 86, 222, 224 |
7 |
AGTR1
| 9件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion, Cortisol synthesis and secretion, Cushing syndrome, Pathways in cancer, Diabetic cardiomyopathy | D00400
D00400
|
Valsartan
| 7件: 57 57, 58, 66, 75, 218, 222, 224 |
8 |
AGTR1
| 9件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion, Cortisol synthesis and secretion, Cushing syndrome, Pathways in cancer, Diabetic cardiomyopathy | D00522
D00522
|
Candesartan
| 2件: 58 58, 67 |
9 |
AGTR1
| 9件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion, Cortisol synthesis and secretion, Cushing syndrome, Pathways in cancer, Diabetic cardiomyopathy | D00523
D00523
|
Irbesartan
| 4件: 66 66, 167, 168, 222 |
10 |
AGTR1
| 9件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion, Cortisol synthesis and secretion, Cushing syndrome, Pathways in cancer, Diabetic cardiomyopathy | D00626
D00626
|
Candesartan cilexetil
| 1件: 67 67 |
11 |
AGTR1
| 9件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion, Cortisol synthesis and secretion, Cushing syndrome, Pathways in cancer, Diabetic cardiomyopathy | D00627
D00627
|
Telmisartan
| 2件: 66 66, 67 |
12 |
AGTR1
| 9件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion, Cortisol synthesis and secretion, Cushing syndrome, Pathways in cancer, Diabetic cardiomyopathy | D02014
D02014
|
Angiotensin II
| 7件: 17 17, 19, 46, 66, 86, 222, 224 |
13 |
AGTR1
| 9件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion, Cortisol synthesis and secretion, Cushing syndrome, Pathways in cancer, Diabetic cardiomyopathy | D08146
D08146
|
Losartan
| 17件: 17 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
14 |
AGTR1
| 9件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion, Cortisol synthesis and secretion, Cushing syndrome, Pathways in cancer, Diabetic cardiomyopathy | D11776
D11776
|
Sparsentan
| 3件: 66 66, 218, 222 |
15 |
KCNA4
| 2件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome | D04127
D04127
|
Dalfampridine
| 5件: 3 3, 4, 6, 13, 14 |
16 |
KCNA4
| 2件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome | D10228
D10228
|
Amifampridine
| 3件: 3 3, 11, 12 |
17 |
MC2R
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Cortisol synthesis and secretion, Cushing syndrome | D00146
D00146
|
Corticotropin
| 12件: 2 2, 13, 14, 46, 49, 50, 66, 75, 81, 84, 145, 222 |
18 |
MC2R
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Cortisol synthesis and secretion, Cushing syndrome | D00284
D00284
|
Tetracosactide
| 5件: 78 78, 83, 113, 145, 222 |
19 |
PDE8A
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, Cortisol synthesis and secretion, Cushing syndrome, Morphine addiction | D00227
D00227
|
Aminophylline
| 1件: 63 63 |
20 |
PDE8A
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, Cortisol synthesis and secretion, Cushing syndrome, Morphine addiction | D00371
D00371
|
Theophylline
| 2件: 236 236, 299 |
21 |
PDE8A
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, Cortisol synthesis and secretion, Cushing syndrome, Morphine addiction | D06103
D06103
|
Theophylline
| 2件: 236 236, 299 |
22 |
PDE8A
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, Cortisol synthesis and secretion, Cushing syndrome, Morphine addiction | D07546
D07546
|
Bucladesine
| 1件: 246 246 |
23 |
PDE8A
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, Cortisol synthesis and secretion, Cushing syndrome, Morphine addiction | D07961
D07961
|
Flavoxate
| 1件: 226 226 |
24 |
CACNA1C
| 22件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Taste transduction, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D00349
D00349
|
Isradipine
| 1件: 6 6 |
25 |
CACNA1C
| 22件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Taste transduction, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D00437
D00437
|
Nifedipine
| 2件: 50 50, 81 |
26 |
CACNA1C
| 22件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Taste transduction, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
27 |
CACNA1C
| 22件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Taste transduction, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D01173
D01173
|
Cilnidipine
| 1件: 67 67 |
28 |
CACNA1C
| 22件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Taste transduction, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D01908
D01908
|
Nilvadipine
| 1件: 90 90 |
29 |
CACNA1C
| 22件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Taste transduction, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D02356
D02356
|
Verapamil
| 4件: 58 58, 96, 140, 167 |
30 |
CACNA1C
| 22件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Taste transduction, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D07450
D07450
|
Amlodipine
| 4件: 13 13, 51, 67, 298 |
31 |
CACNA1C
| 22件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Taste transduction, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D07845
D07845
|
Diltiazem
| 3件: 51 51, 58, 86 |
32 |
CACNA1C
| 22件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Taste transduction, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D08270
D08270
|
Nicardipine
| 2件: 70 70, 86 |
33 |
CACNA1C
| 22件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Taste transduction, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D08340
D08340
|
Perhexiline
| 2件: 58 58, 272 |
34 |
CACNA1C
| 22件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Taste transduction, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D08441
D08441
|
Propiverine
| 1件: 226 226 |
35 |
CACNA1D
| 21件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Glutamatergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D00349
D00349
|
Isradipine
| 1件: 6 6 |
36 |
CACNA1D
| 21件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Glutamatergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D00437
D00437
|
Nifedipine
| 2件: 50 50, 81 |
37 |
CACNA1D
| 21件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Glutamatergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
38 |
CACNA1D
| 21件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Glutamatergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D01173
D01173
|
Cilnidipine
| 1件: 67 67 |
39 |
CACNA1D
| 21件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Glutamatergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D01908
D01908
|
Nilvadipine
| 1件: 90 90 |
40 |
CACNA1D
| 21件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Glutamatergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D02356
D02356
|
Verapamil
| 4件: 58 58, 96, 140, 167 |
41 |
CACNA1D
| 21件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Glutamatergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D07450
D07450
|
Amlodipine
| 4件: 13 13, 51, 67, 298 |
42 |
CACNA1D
| 21件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Glutamatergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D07845
D07845
|
Diltiazem
| 3件: 51 51, 58, 86 |
43 |
CACNA1D
| 21件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Glutamatergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D08270
D08270
|
Nicardipine
| 2件: 70 70, 86 |
44 |
CACNA1D
| 21件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Glutamatergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D08340
D08340
|
Perhexiline
| 2件: 58 58, 272 |
45 |
CACNA1D
| 21件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Tight junction, Retrograde endocannabinoid signaling, Glutamatergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D08441
D08441
|
Propiverine
| 1件: 226 226 |
46 |
CACNA1F
| 17件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D00349
D00349
|
Isradipine
| 1件: 6 6 |
47 |
CACNA1F
| 17件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D00437
D00437
|
Nifedipine
| 2件: 50 50, 81 |
48 |
CACNA1F
| 17件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
49 |
CACNA1F
| 17件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D01173
D01173
|
Cilnidipine
| 1件: 67 67 |
50 |
CACNA1F
| 17件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D01908
D01908
|
Nilvadipine
| 1件: 90 90 |
51 |
CACNA1F
| 17件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D02356
D02356
|
Verapamil
| 4件: 58 58, 96, 140, 167 |
52 |
CACNA1F
| 17件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D07450
D07450
|
Amlodipine
| 4件: 13 13, 51, 67, 298 |
53 |
CACNA1F
| 17件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D07845
D07845
|
Diltiazem
| 3件: 51 51, 58, 86 |
54 |
CACNA1F
| 17件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D08270
D08270
|
Nicardipine
| 2件: 70 70, 86 |
55 |
CACNA1F
| 17件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D08340
D08340
|
Perhexiline
| 2件: 58 58, 272 |
56 |
CACNA1F
| 17件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D08441
D08441
|
Propiverine
| 1件: 226 226 |
57 |
CACNA1S
| 17件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D00349
D00349
|
Isradipine
| 1件: 6 6 |
58 |
CACNA1S
| 17件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D00437
D00437
|
Nifedipine
| 2件: 50 50, 81 |
59 |
CACNA1S
| 17件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D00537
D00537
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 |
60 |
CACNA1S
| 17件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D01173
D01173
|
Cilnidipine
| 1件: 67 67 |
61 |
CACNA1S
| 17件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D01908
D01908
|
Nilvadipine
| 1件: 90 90 |
62 |
CACNA1S
| 17件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D02356
D02356
|
Verapamil
| 4件: 58 58, 96, 140, 167 |
63 |
CACNA1S
| 17件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D07450
D07450
|
Amlodipine
| 4件: 13 13, 51, 67, 298 |
64 |
CACNA1S
| 17件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D07845
D07845
|
Diltiazem
| 3件: 51 51, 58, 86 |
65 |
CACNA1S
| 17件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D08270
D08270
|
Nicardipine
| 2件: 70 70, 86 |
66 |
CACNA1S
| 17件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D08340
D08340
|
Perhexiline
| 2件: 58 58, 272 |
67 |
CACNA1S
| 17件: MAPK signaling pathway MAPK signaling pathway, Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome, Growth hormone synthesis, secretion and action, Prion disease, Pathways of neurodegeneration - multiple diseases, Hypertrophic cardiomyopathy, Dilated cardiomyopathy | D08441
D08441
|
Propiverine
| 1件: 226 226 |
68 |
PDE8B
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, Cortisol synthesis and secretion, Cushing syndrome, Morphine addiction | D00227
D00227
|
Aminophylline
| 1件: 63 63 |
69 |
PDE8B
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, Cortisol synthesis and secretion, Cushing syndrome, Morphine addiction | D00371
D00371
|
Theophylline
| 2件: 236 236, 299 |
70 |
PDE8B
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, Cortisol synthesis and secretion, Cushing syndrome, Morphine addiction | D06103
D06103
|
Theophylline
| 2件: 236 236, 299 |
71 |
PDE8B
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, Cortisol synthesis and secretion, Cushing syndrome, Morphine addiction | D07546
D07546
|
Bucladesine
| 1件: 246 246 |
72 |
PDE8B
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, Cortisol synthesis and secretion, Cushing syndrome, Morphine addiction | D07961
D07961
|
Flavoxate
| 1件: 226 226 |
73 |
CACNA1I
| 4件: MAPK signaling pathway MAPK signaling pathway, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome | D00399
D00399
|
Valproic acid
| 14件: 2 2, 3, 5, 6, 13, 26, 65, 85, 90, 102, 127, 222, 233, 256 |
74 |
CACNA1I
| 4件: MAPK signaling pathway MAPK signaling pathway, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome | D00538
D00538
|
Zonisamide
| 1件: 6 6 |
75 |
CACNA1I
| 4件: MAPK signaling pathway MAPK signaling pathway, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome | D07971
D07971
|
Flunarizine
| 1件: 149 149 |
76 |
CACNA1H
| 4件: MAPK signaling pathway MAPK signaling pathway, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome | D00399
D00399
|
Valproic acid
| 14件: 2 2, 3, 5, 6, 13, 26, 65, 85, 90, 102, 127, 222, 233, 256 |
77 |
CACNA1H
| 4件: MAPK signaling pathway MAPK signaling pathway, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome | D00538
D00538
|
Zonisamide
| 1件: 6 6 |
78 |
CACNA1H
| 4件: MAPK signaling pathway MAPK signaling pathway, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome | D07971
D07971
|
Flunarizine
| 1件: 149 149 |
79 |
CACNA1G
| 5件: MAPK signaling pathway MAPK signaling pathway, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome | D00399
D00399
|
Valproic acid
| 14件: 2 2, 3, 5, 6, 13, 26, 65, 85, 90, 102, 127, 222, 233, 256 |
80 |
CACNA1G
| 5件: MAPK signaling pathway MAPK signaling pathway, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome | D00538
D00538
|
Zonisamide
| 1件: 6 6 |
81 |
CACNA1G
| 5件: MAPK signaling pathway MAPK signaling pathway, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome | D07971
D07971
|
Flunarizine
| 1件: 149 149 |